Comparative study on application of 177 Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy

Added 529 days ago (19.01.2021)
Authors: Hesham MH Zakaly, Mostafa Y A Mostafa, Sergey Dzholumbetov, Shams A M Issa, H O Tekin, R Uslu Erdemir and M Zhukovsky
Read article